Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019
The Food and Drug Administration approved tafenoquine for prophylaxis of malaria and antirelapse therapy.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Malaria MMWR Morbidity & Mortality Weekly Report Outbreaks Salmonella Source Type: news
More News: American Health | Food and Drug Administration (FDA) | Malaria | Outbreaks | Salmonella | USA Health